HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $61,686,285 | +36.9% | 1,084,118 | -4.8% | 7.80% | +35.3% |
| Q3 2022 | $45,043,000 | -32.9% | 1,139,170 | -25.4% | 5.76% | -24.9% |
| Q2 2022 | $67,157,000 | +8.9% | 1,526,293 | -1.3% | 7.67% | +41.8% |
| Q1 2022 | $61,678,000 | +2.3% | 1,546,592 | +3.1% | 5.41% | +12.2% |
| Q4 2021 | $60,298,000 | -1.6% | 1,499,576 | -0.5% | 4.82% | -6.0% |
| Q3 2021 | $61,283,000 | -0.1% | 1,506,473 | +11.5% | 5.13% | +1.3% |
| Q2 2021 | $61,343,000 | +8.7% | 1,350,870 | -0.2% | 5.06% | +0.7% |
| Q1 2021 | $56,415,000 | +13.5% | 1,353,208 | +16.3% | 5.03% | +9.2% |
| Q4 2020 | $49,709,000 | +74.5% | 1,163,881 | +7.4% | 4.60% | +50.1% |
| Q3 2020 | $28,488,000 | +6.1% | 1,084,015 | +8.2% | 3.07% | -1.3% |
| Q2 2020 | $26,849,000 | – | 1,001,447 | – | 3.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |